CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Executive or director change
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Other events
- 4 Grant or award Executive VP and COO acquired 150,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award SVP and CFO acquired 75,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 300,000 shares at $3.08 ($923,130)
- 4 Grant or award President and CEO acquired 500,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
Page 38 of 62 · 1,224 filings